biotech
Bio-AnalystSupplement research
person

Biotin

Selected research topic

Glucose and metabolic health

Confirmed comparison evidence for this topic is limited. The findings below retain their study conditions.

Findings from a combination study cannot be attributed to this ingredient alone.

Some publications still need interpretation checks and are kept separate from the findings below.

Animal and cell findings do not establish the same effect in people.

Publications for this topic
3
Human comparison publications
0
Publications needing review
2

Findings in the studies

  • hypoglycemic effect of the nanocomplexes

    Animal and cell research · indirect evidence
    • A change was reported in animal or cell research.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Combination study
      Measurement and study conditions
      Study type
      Animal study · indirect
      Study population
      This is animal research. The specific characteristics of the subjects need further review.
      Ingredients tested
      Ingredient combination
      How results were compared
      Comparison unclear · Study comparison: different biotin modification degrees and HA molecular weights; no simple biotin-only contrast state
      Additional measurement information
      Mechanistic outcome
      Measurement time
      Not confirmed.
  • insulin

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Single ingredient · 28 to 90 days
      Measurement and study conditions
      Study type
      Meta-analysis
      Study population
      Recorded population category: Patient group. Whether the research involved humans needs confirmation.
      Ingredients tested
      Single ingredient
      How results were compared
      Study comparison: Pooled biotin supplementation outcome across included RCTs; comparator details not reported
      Measurement time
      28 to 90 days

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (2)
  • Fasting Blood Glucose · Distinct papers needing additional review: 1Direction unclear: 1
  • weight gain · Distinct papers needing additional review: 1Evidence criteria check: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Representative outcome and study details

Animal studies reported improvement in hypoglycemic effect of the nanocomplexes.

combination-ingredient studies · Individual ingredient effects cannot be separated · Animal studies; human applicability unconfirmed · Includes patient groups · comparator not confirmed

1 publications linked to this result

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
  • Combination, formula, or class studies do not isolate this ingredient or establish synergy.
  • Animal and cell findings are indirect evidence.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: Not yet rated

The 0.0 evidence score includes 0 independent human studies and 0 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 88

Papers linked to this topic 3 · distinct papers 3 · comparison findings need further review · papers needing additional review 2

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • Fasting Blood Glucose: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • hypoglycemic effect of the nanocomplexes: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • insulin: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • weight gain: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

What the research found

insulin

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

hypoglycemic effect of the nanocomplexes

A change was reported in animal or cell research.

Animal study · indirect · Ingredient combination · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Fasting Blood Glucose

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

weight gain

The study needs further checking before its result can be interpreted.

Animal study · indirect · Ingredient combination · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No combination cautions are available to show in the current data. This does not guarantee safety.

Side effects and combination studies

No side-effect or combination findings are available to show from the collected papers. This does not establish safety.